146 related articles for article (PubMed ID: 16750546)
21. Safety studies of a recently developed microbicidal contraceptive gel (UniPron) in female baboons (Papio anubis).
Mburu N; Obiero JA; Waititu K; Mwaura BN; Orawo JO; Farah IO; Mwethera PG
Afr J Reprod Health; 2009 Dec; 13(4):95-104. PubMed ID: 20690277
[TBL] [Abstract][Full Text] [Related]
22. Safety of intrauterine administration of purified neem seed oil (Praneem Vilci) in women & effect of its co-administration with the heterospecies dimer birth control vaccine on antibody response to human chorionic gonadotropin.
Talwar GP; Pal R; Singh O; Garg S; Taluja V; Upadhyay SN; Gopalan S; Jain V; Kaur J; Sehgal S
Indian J Med Res; 1995 Aug; 102():66-70. PubMed ID: 8834816
[TBL] [Abstract][Full Text] [Related]
23. [Local spermicidal contraception].
Marmor D
Gynecol Obstet Fertil; 2001 Oct; 29(10):705-13. PubMed ID: 11732437
[No Abstract] [Full Text] [Related]
24. A randomized controlled safety trial of the diaphragm and cellulose sulfate microbicide gel in sexually active women in Zimbabwe.
van der Straten A; Napierala S; Cheng H; Mauck C; Depineres T; Dhlakama P; Thompson M; Chipato T; Hammond N; Padian N
Contraception; 2007 Nov; 76(5):389-99. PubMed ID: 17963865
[TBL] [Abstract][Full Text] [Related]
25. Differentiating normal from abnormal rates of genital epithelial findings in vaginal microbicide trials.
van de Wijgert JH; Kilmarx PH; Jones HE; Karon JM; Chaikummao S
Contraception; 2008 Feb; 77(2):122-9. PubMed ID: 18226677
[TBL] [Abstract][Full Text] [Related]
26. Gel-microemulsions as vaginal spermicides and intravaginal drug delivery vehicles.
D'Cruz OJ; Uckun FM
Contraception; 2001 Aug; 64(2):113-23. PubMed ID: 11704088
[TBL] [Abstract][Full Text] [Related]
27. Safety, tolerance and acceptability of the Invisible Condom and its vaginal applicator in healthy women and their male sexual partners.
Trottier S; Omar RF; Désormeaux A; Drouin J; Gagnon MT; Vezina F; Guilbert E; Mâsse B; Bergeron MG
Contraception; 2007 Aug; 76(2):117-25. PubMed ID: 17656181
[TBL] [Abstract][Full Text] [Related]
28. ACIDFORM: a review of the evidence.
Bayer LL; Jensen JT
Contraception; 2014 Jul; 90(1):11-8. PubMed ID: 24565736
[TBL] [Abstract][Full Text] [Related]
29. [Patentex Oval N - a modern local contraceptive].
Libra Pharma.
Akush Ginekol (Sofiia); 2000; 39 Suppl 2():26-7. PubMed ID: 11188013
[No Abstract] [Full Text] [Related]
30. Local spermicidal contraception: a comparative study of the acceptability and safety of a new pharmaceutical formulation of benzalkonium chloride, the vaginal capsule, with a reference formulation, the pessary.
Aubeny E; Colau JC; Nandeuil A
Eur J Contracept Reprod Health Care; 2000 Mar; 5(1):61-7. PubMed ID: 10836664
[TBL] [Abstract][Full Text] [Related]
31. [A clinical study of the local contraceptive C-Film Lucchini].
Porozhanova V; Bozhinova S; Khristova V
Akush Ginekol (Sofiia); 1999; 38(3):54-6. PubMed ID: 10734685
[TBL] [Abstract][Full Text] [Related]
32. Safety and tolerability of the new contraceptive sponge Protectaid.
Creatsas G; Elsheikh A; Colin P
Eur J Contracept Reprod Health Care; 2002 Jun; 7(2):91-5. PubMed ID: 12201327
[TBL] [Abstract][Full Text] [Related]
33. Safety trial of the vaginal microbicide cellulose sulfate gel in HIV-positive men.
Jespers V; Buvé A; Van Damme L
Sex Transm Dis; 2007 Jul; 34(7):519-22. PubMed ID: 17297382
[TBL] [Abstract][Full Text] [Related]
34. Contraceptive efficacy of antimicrobial peptide Nisin: in vitro and in vivo studies.
Aranha C; Gupta S; Reddy KV
Contraception; 2004 Apr; 69(4):333-8. PubMed ID: 15033410
[TBL] [Abstract][Full Text] [Related]
35. Distribution of a vaginal gel (Invisible Condom) before, during and after simulated sexual intercourse and its persistence when delivered by two different vaginal applicators: a magnetic resonance imaging study.
Omar RF; Trottier S; Brousseau G; Lamarre A; Alexandre Gagnon ; Bergeron MG
Contraception; 2008 Jun; 77(6):447-55. PubMed ID: 18477496
[TBL] [Abstract][Full Text] [Related]
36. Postcoital testing after the use of a bio-adhesive acid buffering gel (ACIDFORM) and a 2% nonoxynol-9 product.
Amaral E; Perdigão A; Souza MH; Mauck C; Waller D; Zaneveld L; Faúndes A
Contraception; 2004 Dec; 70(6):492-7. PubMed ID: 15541412
[TBL] [Abstract][Full Text] [Related]
37. A novel polyherbal microbicide with inhibitory effect on bacterial, fungal and viral genital pathogens.
Talwar GP; Dar SA; Rai MK; Reddy KV; Mitra D; Kulkarni SV; Doncel GF; Buck CB; Schiller JT; Muralidhar S; Bala M; Agrawal SS; Bansal K; Verma JK
Int J Antimicrob Agents; 2008 Aug; 32(2):180-5. PubMed ID: 18571386
[TBL] [Abstract][Full Text] [Related]
38. Consistent use of a combination product versus a single product in a safety trial of the diaphragm and microbicide in Harare, Zimbabwe.
van der Straten A; Moore J; Napierala S; Clouse K; Mauck C; Hammond N; Padian N
Contraception; 2008 Jun; 77(6):435-43. PubMed ID: 18477494
[TBL] [Abstract][Full Text] [Related]
39. Safety and tolerability of BufferGel, a novel vaginal microbicide, in women in the United States.
Mayer KH; Peipert J; Fleming T; Fullem A; Moench T; Cu-Uvin S; Bentley M; Chesney M; Rosenberg Z
Clin Infect Dis; 2001 Feb; 32(3):476-82. PubMed ID: 11170957
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of antimicrobial peptide nisin as a safe vaginal contraceptive agent in rabbits: in vitro and in vivo studies.
Reddy KV; Aranha C; Gupta SM; Yedery RD
Reproduction; 2004 Jul; 128(1):117-26. PubMed ID: 15232069
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
